Maura Dandri - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maura Dandri

Showing results (101-110 of 103) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 103 results.

Journal of Hepatology|July 17, 2023

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.

Nature Reviews. Gastroenterology & Hepatology|July 20, 2022

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlookAnna Kramvis, Kyong-Mi Chang, Maura Dandri, et al.

Nature Biotechnology|March 24, 2015

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.

Pageof 11

Search research articles

Showing results (101-110 of 103) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 103 results.

Journal of Hepatology|July 17, 2023

Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized miceFlorian A Lempp, Tassilo Volz, Elisabetta Cameroni, et al.

Nature Reviews. Gastroenterology & Hepatology|July 20, 2022

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlookAnna Kramvis, Kyong-Mi Chang, Maura Dandri, et al.

Nature Biotechnology|March 24, 2015

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyLaurent Mailly, Fei Xiao, Joachim Lupberger, et al.

Pageof 11